Pauline Sabin was a wealthy New York Republican with two sons, and she backed Prohibition for them. She thought it would help her boys, and that a world without liquor would be a better one. By 1929 she had looked at what that world actually did. She quit the Republican National Committee and founded the Women's Organization for National Prohibition Reform, which grew past a million members and helped end the ban (Kyvig, 1976).
What the mothers saw
Nobody could call Sabin soft on children. Protecting them was her whole case. She told a committee of Congress:
"In pre-prohibition days, mothers had little fear in regard to the saloon as far as their children were concerned. A saloon-keeper's license was revoked if he were caught selling liquor to minors. Today in any speakeasy in the United States you can find boys and girls in their teens drinking liquor, and this situation has become so acute that the mothers of the country feel something must be done to protect their children."
Read it again. She'd noticed the thing the debate still misses, nearly a century later. A ban doesn't remove a drug. It removes the shopkeeper, and the shopkeeper is the one person in the sale who has to ask "how old are you?" and refuse. What's left is a seller with no licence to lose.
What comes back is stronger
Prohibition did work at first. Economists who rebuilt the numbers from death, hospital and crime records estimate drinking fell to about 30% of its old level, then climbed back to 60% or 70% (Miron & Zwiebel, 1991). But what came back wasn't the old beer. Smugglers carried spirits, because a strong drink is worth more per bottle hidden. Drug researchers call this the iron law of prohibition, and you can see it today in fentanyl replacing heroin (Beletsky & Davis, 2017).
The bans were never only about harm either. The first drug laws in the United States and Australia were written against minorities. Opium smoking was linked with Chinese labourers and banned, while opiates and cocaine sold freely to middle-class buyers in patent medicines and tonics (Musto, 1999). Australia's early laws did the same, aimed at Chinese communities while opium stayed on chemists' shelves (Manderson, 1993).
So you're saying it's fine for kids to be offered drugs?
No. It happens now. In a 2025 survey of 1,151 British students aged 13 to 18, 29% had seen illegal drugs advertised on social media without looking for them, mostly on Snapchat, Instagram and TikTok (Fuller et al., 2025). In 2017, one American high-school student in five said someone had offered, sold or given them an illegal drug on school property in the past year (Centers for Disease Control and Prevention, 2018).
Nobody intends that. But we know it's the result, and a policy whose known result is children being offered drugs can't defend itself by pointing to what it meant.
Two drugs, the same schools
The US government has asked high-school students about their drug use every two years since 1991, which gives a natural comparison. Cigarettes stayed legal the whole time, but only for adults, behind an ID check, with licences, advertising bans and warnings. Marijuana stayed banned for everyone, or nearly.
In 1997, 36.4% of students had smoked a cigarette in the past month. By 2017 it was 8.8%, down 75.8%. Marijuana went from 26.2% to 19.8%, down 24.4%. By 2017 students were more than twice as likely to use the banned drug as the regulated one.
Part of the fall in smoking came from taxes, ad bans and campaigns, not only ID checks. That's the point. Every one of those tools works on a product sold legally. None of them works on a dealer.
Legal markets can still fail children, and vaping proves it. By 2019, more than a quarter of American high-school students were using e-cigarettes (Cullen et al., 2019), many of them sold in flavours like mango. But look at what parents could do about it: name the companies, drag them to hearings, ban the flavours, raise the age. Try that with a dealer.
What happened when states legalised?
The fear is that legal sales to adults leak to children. Across the US states that legalised marijuana for adults, teen use didn't rise. Compared with other states it fell by 1.3 percentage points, a gap close enough to chance that the fair claim is modest: legal sales didn't draw teenagers in. A study of 1.4 million students found the same, with 8% lower odds of use after adult-use laws (Anderson et al., 2019).
Legal shops aren't perfect. When researchers worked through the checkout at 80 online dispensaries, 18.8% required no formal age verification at any step (Terala et al., 2023). That's an argument for enforcement. The other four in five at least checked, and there's a regulator to tell. Nobody audits a dealer. And rules move the numbers: raising the tobacco age to 21 was estimated to cut initiation among 15- to 17-year-olds by 25% (Institute of Medicine, 2015).
The molecule isn't the difference
Many drugs we call too dangerous for anyone are already prescribed in measured doses. GHB is sold as a narcolepsy medicine. In a placebo-controlled trial, a single dose of ayahuasca eased depression that no other treatment had touched (Palhano-Fontes et al., 2019). The difference between a prescription and a street deal is the dose, the label, the purity, the instructions and the person accountable for them. And the most harmful drug in a British expert ranking of twenty, counting harm to users and to others, was alcohol, on sale on every high street (Nutt et al., 2010).
So the choice was never drugs or no drugs. It's which ones we leave to criminals.
More rules, on people who can be found
Regulation isn't an absence of rules. Picture licensed sellers, ID checks, test purchases by minors and the loss of a licence for selling to one. No marketing to children. Known dose and purity, potency limits, child-resistant packs. Honest education young people can believe. And a young person in trouble with a drug is a patient, not a defendant. That's how we already treat alcohol and tobacco, and it's how teen smoking fell by three-quarters.
Refusing all this means accepting, knowingly, that children go on being offered drugs by people who never ask their age. Saying we didn't mean it is no defence once we know the result.
What you can do
Every parent wants the same thing here. Pauline Sabin wanted it, and she changed her mind out loud, in public, in front of her own party, because her boys mattered more than her position.
- Ask the next person who defends the ban one question: who, under your policy, asks the child how old they are?
- Talk to your kids before someone else does, without the threats. They need to be able to come to you when a mate collapses. The National Alcohol and Other Drug Hotline is 1800 250 015.
- Write to your MP and ask what protects a fifteen-year-old from a dealer. Then listen to the answer.
Sources
Anderson, D. M., Hansen, B., Rees, D. I., & Sabia, J. J. (2019). Association of marijuana laws with teen marijuana use. JAMA Pediatrics, 173(9), 879–881. https://doi.org/10.1001/jamapediatrics.2019.1720
Beletsky, L., & Davis, C. S. (2017). Today's fentanyl crisis: Prohibition's iron law, revisited. International Journal of Drug Policy, 46, 156–159. https://doi.org/10.1016/j.drugpo.2017.05.050
Centers for Disease Control and Prevention. (2018). Youth Risk Behavior Survey: Data summary and trends report, 2007–2017.
Cullen, K. A., Gentzke, A. S., Sawdey, M. D., Chang, J. T., Anic, G. M., Wang, T. W., Creamer, M. R., Jamal, A., Ambrose, B. K., & King, B. A. (2019). e-Cigarette use among youth in the United States, 2019. JAMA, 322(21), 2095–2103. https://doi.org/10.1001/jama.2019.18387
Fuller, A., Vasek, M., Mariconti, E., & Johnson, S. D. (2025). Platforms, risk perceptions, and reporting: The impact of illicit drug advertisements on social media among UK secondary students. Harm Reduction Journal, 22(1), 154. https://doi.org/10.1186/s12954-025-01299-5
Institute of Medicine. (2015). Public health implications of raising the minimum age of legal access to tobacco products. The National Academies Press. https://doi.org/10.17226/18997
Kyvig, D. E. (1976). Women against Prohibition. American Quarterly, 28(4), 465–482. https://doi.org/10.2307/2712541
Manderson, D. (1993). From Mr Sin to Mr Big: A history of Australian drug laws. Oxford University Press.
Miron, J. A., & Zwiebel, J. (1991). Alcohol consumption during Prohibition (NBER Working Paper No. 3675). National Bureau of Economic Research. https://doi.org/10.3386/w3675
Musto, D. F. (1999). The American disease: Origins of narcotic control (3rd ed.). Oxford University Press. https://doi.org/10.1093/oso/9780195125092.001.0001
Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet, 376(9752), 1558–1565. https://doi.org/10.1016/S0140-6736(10)61462-6
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., Tófoli, L. F., de Oliveira Silveira, G., Yonamine, M., Riba, J., Santos, F. R., Silva-Junior, A. A., Alchieri, J. C., Galvão-Coelho, N. L., Lobão-Soares, B., … Araújo, D. B. (2019). Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine, 49(4), 655–663. https://doi.org/10.1017/S0033291718001356
Terala, A., Sangiuolo, K., & Milanaik, R. L. (2023). Access to marijuana by minors via online dispensaries. JAMA Pediatrics, 177(12), 1356. https://doi.org/10.1001/jamapediatrics.2023.3656
Van Cauter, E., Plat, L., Scharf, M. B., Leproult, R., Cespedes, S., L'Hermite-Balériaux, M., & Copinschi, G. (1997). Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. Journal of Clinical Investigation, 100(3), 745–753. https://doi.org/10.1172/JCI119587